A fully automated aseptic fill-finish platform delivers greater speed, flexibility, and quality for the manufacturing of clinical supplies and commercial products. TORONTO, March 31, 2026 /PRNewswire/ ...

RAMSEY, N.J. and BOCA RATON, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to ...

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the ...

ROCKVILLE, Md.--(BUSINESS WIRE)--ABL, Inc. (ABL), a leading contract research, development and biomanufacturing organization to the biopharmaceutical industry worldwide, is proud to announce the ...

New drug development is focused largely on biopharmaceuticals rather than chemicals, which means the resultant drugs tend to be injectable liquids instead of solids. Furthermore, the new drugs are ...

This renovation of the vaccine maker’s Kvistgård plant added on-site aseptic fill-and-finish capabilities, allowing the company to stop outsourcing that portion of the manufacturing process. The ...

A booming biologics market is increasing demand for specialist fill-finish services and prompting contractors to invest in technologies that reduce waste and safeguard these sensitive medicines. The ...